Study areas of sample collection in Ethiopia, eastern Africa حسب Amete Mihret Teshale (12072758)

الموضوعات:

Prevaelnce of different pathogens by location. حسب Amete Mihret Teshale (12072758)

الموضوعات:

Odds ratio of multivariable analysis of factors for Shiga-toxin producing <i>Escherichia coli</i> (<i>stx</i> حسب Amete Mihret Teshale (12072758)

الموضوعات:

Trend of total hospital attendance. حسب Yaw Nyarko Opoku-Boateng (20477302)

"…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …"

Trend of outpatient (OPD) consultations. حسب Yaw Nyarko Opoku-Boateng (20477302)

"…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …"

Variables used for the analysis. حسب Yaw Nyarko Opoku-Boateng (20477302)

"…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …"

Trend of PNC attendance over the period. حسب Yaw Nyarko Opoku-Boateng (20477302)

"…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …"

Trend of ANC attendance over the period. حسب Yaw Nyarko Opoku-Boateng (20477302)

"…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …"

Total hospital attendances by specialty. حسب Yaw Nyarko Opoku-Boateng (20477302)

"…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …"

COVID19 effect on essential services. حسب Admas Abera (11821659)

الموضوعات:

Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It... حسب Felix Alexandre Schoeller (20988295)

الموضوعات:

Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1. حسب Mucahit Gemici (21519313)

One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2. حسب Mucahit Gemici (21519313)

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from off-label medications clinical trials. حسب Filip Stanicic (17808254)

الموضوعات: